The National Academies: Advisers to the Nation on Science, Engineering, and Medicine
NATIONAL ACADEMY OF SCIENCES NATIONAL ACADEMY OF ENGINEERING INSTITUTE OF MEDICINE NATIONAL RESEARCH COUNCIL
Current Operating Status

The National Academies Testimony before Congress

Public Laws Containing Studies for the National Academies

Briefings to Congress

Congressionally Mandated Reports

Policy Statements and Historical Documents

The OCGA staff

Request a Report (Congressional and Government Staff Only)


Mailing Address:
The Office of Congressional and Government Affairs
The Keck Center of the National Academies
Keck WS1008
500 Fifth Street, NW
Washington, DC 20001
Tel: (202) 334-1601
Fax: (202) 334-2419

Back to Main Page

Briefing Date:02/11/2013
Topic:Countering the Problem of Falsified and Substandard Drugs

THE NATIONAL ACADEMIES
Institute of Medicine
Board on Global Health
Committee on Understanding the Global Public Health Implications
of Substandard, Falsified, and Counterfeit Medical Products

*****

Congressional Briefings
Monday, February 11, 2013
2322 Rayburn House Office Bldg. – 2:00 p.m.
and
430 Dirksen Senate Office Bldg. – 3:00 p.m.

on

Countering the Problem of Falsified and Substandard Drugs

This new report, from the Institute of Medicine, explores the magnitude and impact of illegitimate, poor-quality medications and recommends steps to improve countries' capacity to regulate the production and distribution of drugs, detect fake or subpar products, and close gaps that allow products to be falsified or diluted.

These series of briefings were for members of Congress and congressional staff only. The report was publicly released on February 13, 2013 and can be found, in its entirety, on the Web site of the National Academies Press.

RSS News Feed | Subscribe to e-newsletters | Feedback | Back to Top